BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12773510)

  • 1. Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation.
    Xie JH; Nomura N; Lu M; Chen SL; Koch GE; Weng Y; Rosa R; Di Salvo J; Mudgett J; Peterson LB; Wicker LS; DeMartino JA
    J Leukoc Biol; 2003 Jun; 73(6):771-80. PubMed ID: 12773510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-gamma via CXCR3 chemokines.
    Akahira-Azuma M; Szczepanik M; Tsuji RF; Campos RA; Itakura A; Mobini N; McNiff J; Kawikova I; Lu B; Gerard C; Pober JS; Askenase PW
    Immunology; 2004 Mar; 111(3):306-17. PubMed ID: 15009431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique pattern of up- and down-regulation of chemokine receptor CXCR3 on inflammation-inducing Th1 cells.
    Chen J; Vistica BP; Takase H; Ham DI; Fariss RN; Wawrousek EF; Chan CC; DeMartino JA; Farber JM; Gery I
    Eur J Immunol; 2004 Oct; 34(10):2885-94. PubMed ID: 15368305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT1 in peripheral tissue differentially regulates homing of antigen-specific Th1 and Th2 cells.
    Mikhak Z; Fleming CM; Medoff BD; Thomas SY; Tager AM; Campanella GS; Luster AD
    J Immunol; 2006 Apr; 176(8):4959-67. PubMed ID: 16585592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen-induced Th2 lung inflammation but is only a weak mediator of chemotaxis.
    Latta M; Mohan K; Issekutz TB
    Immunology; 2007 Aug; 121(4):555-64. PubMed ID: 17437534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
    Balashov KE; Rottman JB; Weiner HL; Hancock WW
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
    Stanford MM; Issekutz TB
    J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.
    Manicone AM; Burkhart KM; Lu B; Clark JG
    Exp Lung Res; 2008 Sep; 34(7):391-407. PubMed ID: 18716926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome.
    Hildebrandt GC; Corrion LA; Olkiewicz KM; Lu B; Lowler K; Duffner UA; Moore BB; Kuziel WA; Liu C; Cooke KR
    J Immunol; 2004 Aug; 173(3):2050-9. PubMed ID: 15265940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production.
    Romagnani P; Maggi L; Mazzinghi B; Cosmi L; Lasagni L; Liotta F; Lazzeri E; Angeli R; Rotondi M; Filì L; Parronchi P; Serio M; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2005 Dec; 116(6):1372-9. PubMed ID: 16337473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
    Qin S; Rottman JB; Myers P; Kassam N; Weinblatt M; Loetscher M; Koch AE; Moser B; Mackay CR
    J Clin Invest; 1998 Feb; 101(4):746-54. PubMed ID: 9466968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
    Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
    J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
    Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD
    J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
    Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
    J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
    Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
    J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
    Morimoto Y; Bian Y; Gao P; Yashiro-Ohtani Y; Zhou XY; Ono S; Nakahara H; Kogo M; Hamaoka T; Fujiwara H
    J Leukoc Biol; 2005 Sep; 78(3):753-61. PubMed ID: 16126843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3.
    Gao P; Zhou XY; Yashiro-Ohtani Y; Yang YF; Sugimoto N; Ono S; Nakanishi T; Obika S; Imanishi T; Egawa T; Nagasawa T; Fujiwara H; Hamaoka T
    J Leukoc Biol; 2003 Feb; 73(2):273-80. PubMed ID: 12554804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel chemokine-mediated in vivo T cell recruitment assay.
    Campanella GS; Medoff BD; Manice LA; Colvin RA; Luster AD
    J Immunol Methods; 2008 Feb; 331(1-2):127-39. PubMed ID: 18206159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.